Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Apollo Endosurgery (0) Acquired (3)
bevacizumab (avastin) (1 trial)
ranibizumab (lucentis) (1 trial)
sonepcizumab (5 trials)
Key: Apollo Endosurgery (0) Acquired (2)
lpathomab (1 trial)
sodium chloride (1 trial)
Trials (6 total)
Trial APIs (5 total)